SLC6A3 and Parkinson disease: New imaging methods like positron emission tomography (PET), magnetic resonance imaging (MRI), and dopamine transporter scan (DaTscan) have improved our ability to understand, detect early, and track both movement and non-movement symptoms of PD, leading to better management approaches.